SCHEMBL371925

SCHEMBL371925

O=C(O)CCC(O)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6913774 1.00
SCHEMBL3755409 1.00
SCHEMBL10354453 0.83
SCHEMBL27768874 0.81 LMNA (0.55)
SCHEMBL28783402 0.81 LMNA (0.55)
SCHEMBL27907123 0.81 LMNA (0.55)
SCHEMBL8894698 0.79 LMNA (0.57)
SCHEMBL28574666 0.79 LMNA (0.57)
SCHEMBL11765423 0.79 FOLH1 (0.55)
SCHEMBL911280 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090324682-A1 Medical stent provided with inhibitors of atp synthesis INTERSTITIAL THERAPEUTICS (CH) 2009-12-31 US claimed
EP-1789029-A2 METHODS AND COMPOSITIONS FOR THE TREATMENT OF CELL PROLIFERATION Interstitial Therapeutics (CH) 2007-05-30 EP claimed
EP-1789030-A2 MEDICAL IMPLANT PROVIDED WITH INHIBITORS OF ATP SYNTHESIS Interstitial Therapeutics (CH) 2007-05-30 EP claimed
EP-1789107-A2 MEDICAL STENT PROVIDED WITH INHIBITORS OF ATP SYNTHESIS Interstitial Therapeutics (CH) 2007-05-30 EP claimed
WO-2006024489-A2 METHODS AND COMPOSITIONS FOR THE TREATMENT OF CELL PROLIFERATION INTERSTITIAL THERAPEUTICS (CH) 2006-03-09 WO claimed
WO-2006024488-A2 MEDICAL STENT PROVIDED WITH INHIBITORS OF ATP SYNTHESIS INTERSTITIAL THERAPEUTICS (CH) 2006-03-09 WO claimed
WO-2006024491-A1 METHODS AND COMPOSITIONS FOR THE TREATMENT OF CELL PROLIFERATION INTERSTITIAL THERAPEUTICS (CH) 2006-03-09 WO claimed
WO-2006024492-A2 MEDICAL IMPLANT PROVIDED WITH INHIBITORS OF ATP SYNTHESIS INTERSTITIAL THERAPEUTICS (CH) 2006-03-09 WO claimed
CN-106458957-A Novel cell-permeable succinate compounds 纽维制药有限公司 2017-02-22 CN disclosed
EP-2595951-B1 A PROCESS FOR THE PRODUCTION OF CARNITINE LONZA AG (CH) 2014-04-16 EP disclosed
US-8563752-B2 Process for the production of carnitine by cycloaddition LONZA LTD. (CH) 2013-10-22 US disclosed
EP-2595951-A1 A PROCESS FOR THE PRODUCTION OF CARNITINE Lonza Ltd. (CH) 2013-05-29 EP disclosed
US-20120022275-A1 PROCESS FOR THE PRODUCTION OF CARNITINE BY CYCLOADDITION LONZA LTD. (CH) 2012-01-26 US disclosed
WO-2012010296-A1 A PROCESS FOR THE PRODUCTION OF CARNITINE LONZA LTD (CH) 2012-01-26 WO disclosed
WO-2006024489-A2 METHODS AND COMPOSITIONS FOR THE TREATMENT OF CELL PROLIFERATION INTERSTITIAL THERAPEUTICS (CH) 2006-03-09 WO disclosed
EP-0467132-B1 4-Substituted-2-hydroxybutanoates and a process for producing them CHISSO CORP (JP) 1997-01-22 EP disclosed
US-5324852-A Ring opening optically active a-hydroxybutyrolactone; esterification CHISSO CORPORATION (JP) 1994-06-28 US disclosed
EP-0467132-A2 4-Substituted-2-hydroxybutanoates and a process for producing them CHISSO CORPORATION (JP) 1992-01-22 EP disclosed
US-4940823-A Process for optically active 3-thiolanyl sulfonate esters PFIZER INC. (US) 1990-07-10 US disclosed
US-4921972-A Process for optically active 3-thiolanyl sulfonate esters PFIZER INC. (US) 1990-05-01 US disclosed